Hematopoietic Stem Cell TransplantationBone Marrow TransplantationTransplantation, HomologousHematopoietic Stem CellsGraft vs Host DiseaseBone MarrowTransplantation, AutologousTransplantation ConditioningBone Marrow CellsStem Cell TransplantationHematologic NeoplasmsStem CellsHepatic Veno-Occlusive DiseaseHistocompatibility TestingPeripheral Blood Stem Cell TransplantationHematopoiesisTreatment OutcomeImmunocompromised HostTransplantation ChimeraImmunosuppressive AgentsBone and BonesTissue DonorsWhole-Body IrradiationLeukemiaCell DifferentiationMice, Inbred C57BLAnemia, AplasticGraft SurvivalStem Cell NicheAntigens, CD34Liver TransplantationRetrospective StudiesColony-Forming Units AssayCell LineageBusulfanFlow CytometryAdult Stem CellsHistocompatibilityHematopoietic Stem Cell MobilizationBone Marrow PurgingPancytopeniaCells, CulturedMesenchymal Stem Cell TransplantationTransplantationBone Marrow DiseasesRecurrenceKidney TransplantationEmbryonic Stem CellsCord Blood Stem Cell TransplantationCyclophosphamideCombined Modality TherapyHLA AntigensTransplantation, IsogeneicTime FactorsLeukemia, Myeloid, AcuteRemission InductionFetal BloodBone Marrow ExaminationCell ProliferationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveRadiation ChimeraCell TransplantationMultiple MyelomaBone RemodelingTransplantation ImmunologyMyelodysplastic SyndromesStromal CellsBone Marrow NeoplasmsGraft RejectionPrecursor Cell Lymphoblastic Leukemia-LymphomaHematologic DiseasesGraft vs Leukemia EffectGranulocyte Colony-Stimulating FactorMesenchymal Stromal CellsFollow-Up StudiesSurvival AnalysisCell SeparationMelphalanMyeloablative AgonistsT-LymphocytesCell CountPluripotent Stem CellsChimerismHeart TransplantationLymphocyte DepletionLeukemia, MyeloidStem Cell FactorLymphoma, Non-HodgkinSevere Combined ImmunodeficiencyImmunosuppressionSurvival RateAcute DiseaseMultipotent Stem CellsAntineoplastic Combined Chemotherapy ProtocolsLymphocyte TransfusionDisease-Free SurvivalGraft vs Tumor EffectLung TransplantationBone DensityChimera